GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptamer Group PLC (STU:P0J) » Definitions » COGS-to-Revenue

Aptamer Group (STU:P0J) COGS-to-Revenue : 0.44 (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Aptamer Group COGS-to-Revenue?

Aptamer Group's Cost of Goods Sold for the six months ended in Dec. 2024 was €0.35 Mil. Its Revenue for the six months ended in Dec. 2024 was €0.79 Mil.

Aptamer Group's COGS to Revenue for the six months ended in Dec. 2024 was 0.44.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Aptamer Group's Gross Margin % for the six months ended in Dec. 2024 was 56.22%.


Aptamer Group COGS-to-Revenue Historical Data

The historical data trend for Aptamer Group's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptamer Group COGS-to-Revenue Chart

Aptamer Group Annual Data
Trend Mar19 Mar20 Jun22 Jun23 Jun24
COGS-to-Revenue
0.38 0.47 0.33 0.80 0.71

Aptamer Group Semi-Annual Data
Mar19 Mar20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only 0.55 1.13 1.09 0.51 0.44

Aptamer Group COGS-to-Revenue Calculation

Aptamer Group's COGS to Revenue for the fiscal year that ended in Jun. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.721 / 1.016
=0.71

Aptamer Group's COGS to Revenue for the quarter that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0.345 / 0.788
=0.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aptamer Group  (STU:P0J) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Aptamer Group's Gross Margin % for the six months ended in Dec. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0.345 / 0.788
=56.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Aptamer Group COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Aptamer Group's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Aptamer Group Business Description

Traded in Other Exchanges
Address
Innovation Way, Windmill House, York, GBR, YO10 5BR
Aptamer Group PLC provides Optimer binders for use in research, diagnostics and therapeutics. It strives to deliver transformational solutions that meet the needs of researchers and developers across the life sciences through the use of its proprietary Optimer technology. Its businesses: Aptamer Solutions for custom Optimer development, Aptamer Diagnostics for in-house and collaborative Optimer-based diagnostic development and Aptamer Therapeutics for the development of Optimer-based therapeutics. The Group represents a single operating segment being research and experimental development of biotechnology. It operates in United Kingdom, Europe, USA and other; Geographically earning maximum revenue from USA.

Aptamer Group Headlines

No Headlines